| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |